Publications
Detailed Information
Region-specific changes in the immunoreactivity of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC(2), and PAC(1) receptor) in the aged rat brains
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jae Chul | - |
dc.contributor.author | Cho, Yu Jin | - |
dc.contributor.author | Kim, Jandi | - |
dc.contributor.author | Kim, Nahee | - |
dc.contributor.author | Cha, Choong Ik | - |
dc.contributor.author | Joo, Kyeung Min | - |
dc.contributor.author | Kang, Bong Gu | - |
dc.date.accessioned | 2012-07-10T04:24:30Z | - |
dc.date.available | 2012-07-10T04:24:30Z | - |
dc.date.issued | 2010-09-10 | - |
dc.identifier.citation | BRAIN RESEARCH; Vol.1351; 32-40 | ko_KR |
dc.identifier.issn | 0006-8993 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78694 | - |
dc.description.abstract | Pituitary adenylate cyclase-activating peptide (PACAP) and vasoactive intestinal peptide (VIP) have been implicated in a large array of physiological and patho-physiological processes through their receptors (VPAC(1), VPAC(2), and PAC(1) receptor) in the central nervous system. Previously, we demonstrated age-related decreases in VPAC(1) receptor expression in the rat brain providing a possible basis of several age-induced functional changes in the aged brain. In the current study, we also examined age-related changes in PAC(1) and VPAC(2) receptors in aged rat brains using an immunohistochemical approach. We found that PAC(1) immunoreactivity was significantly increased in the hippocampal formation, hypothalamus, thalamus, midbrain septal nuclei, and white matter of aged rats compared with young control rats although its distribution pattern was not altered. In contrast, both distribution pattern and immunoreactivity of VPAC(2) receptor remained unchanged in aged rat brains. These results suggest that the PACAP/VIP receptors exhibit specific expressional changes in the aged brain and that these specific changes could underlie age-associated memory and cognitive functional declines as well as several other age-induced functional changes in the brain. However, the exact regulatory mechanism and its functional significance require further elucidation. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ELSEVIER SCIENCE BV | ko_KR |
dc.subject | VPAC(2) receptor | ko_KR |
dc.subject | Immunohistochemistry | ko_KR |
dc.subject | PAC(1) receptor | ko_KR |
dc.subject | Aged rat brain | ko_KR |
dc.subject | Expressional change | ko_KR |
dc.title | Region-specific changes in the immunoreactivity of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC(2), and PAC(1) receptor) in the aged rat brains | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이재철 | - |
dc.contributor.AlternativeAuthor | 조유진 | - |
dc.contributor.AlternativeAuthor | 김잔디 | - |
dc.contributor.AlternativeAuthor | 김나희 | - |
dc.contributor.AlternativeAuthor | 강봉구 | - |
dc.contributor.AlternativeAuthor | 차중익 | - |
dc.contributor.AlternativeAuthor | 주경민 | - |
dc.identifier.doi | 10.1016/j.brainres.2010.06.048 | - |
dc.citation.journaltitle | BRAIN RESEARCH | - |
dc.description.citedreference | Peters A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.011.2009 | - |
dc.description.citedreference | Hansson E, 2009, NEUROREPORT, V20, P957, DOI 10.1097/WNR.0b013e32832ca201 | - |
dc.description.citedreference | Downs JL, 2009, MOL CELL ENDOCRINOL, V299, P32, DOI 10.1016/j.mce.2008.11.012 | - |
dc.description.citedreference | JOLIVEL V, 2009, NEUROSCIENCE, V60, P434 | - |
dc.description.citedreference | Dejda A, 2008, J MOL NEUROSCI, V36, P26, DOI 10.1007/s12031-008-9087-1 | - |
dc.description.citedreference | Peters A, 2008, GLIA, V56, P1151, DOI 10.1002/glia.20686 | - |
dc.description.citedreference | Guillot TS, 2008, NEUROPEPTIDES, V42, P423, DOI 10.1016/j.npep.2008.04.003 | - |
dc.description.citedreference | Brenneman DE, 2007, PEPTIDES, V28, P1720, DOI 10.1016/j.peptides.2007.04.002 | - |
dc.description.citedreference | Reglodi D, 2006, NEUROPEPTIDES, V40, P265, DOI 10.1016/j.npep.2006.06.001 | - |
dc.description.citedreference | Aujard F, 2006, CHRONOBIOL INT, V23, P451, DOI 10.1080/07420520500482090 | - |
dc.description.citedreference | Gomariz RP, 2006, ANN NY ACAD SCI, V1070, P51, DOI 10.1196/annals.1317.031 | - |
dc.description.citedreference | Dejda A, 2006, ANN NY ACAD SCI, V1070, P220, DOI 10.1196/annals.1317.018 | - |
dc.description.citedreference | VAUDRY H, 2006, ANN NY ACAD SCI, V1070, P1 | - |
dc.description.citedreference | Joo KM, 2005, BRAIN RES, V1064, P166, DOI 10.1016/j.brainres.2005.09.006 | - |
dc.description.citedreference | Peters A, 2004, CEREB CORTEX, V14, P995 | - |
dc.description.citedreference | Joo KM, 2004, J COMP NEUROL, V476, P388, DOI 10.1002/cne.20231 | - |
dc.description.citedreference | Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001 | - |
dc.description.citedreference | Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9 | - |
dc.description.citedreference | Nonaka N, 2002, PEPTIDES, V23, P2197 | - |
dc.description.citedreference | Krajnak K, 2002, BRAIN RES, V950, P297 | - |
dc.description.citedreference | Vaudry D, 2002, EUR J NEUROSCI, V15, P1451, DOI 10.1046/j.1460-9568.2002.01981.x | - |
dc.description.citedreference | Laburthe M, 2002, RECEPTOR CHANNEL, V8, P137, DOI 10.1080/10606820290005191 | - |
dc.description.citedreference | Wiemelt AP, 2001, J NEUROSCI RES, V65, P165 | - |
dc.description.citedreference | Lee M, 2001, J NEUROSCI, V21, P3849 | - |
dc.description.citedreference | Duncan MJ, 2001, MOL BRAIN RES, V87, P196 | - |
dc.description.citedreference | Sherwood NM, 2000, ENDOCR REV, V21, P619 | - |
dc.description.citedreference | Krajnak K, 1998, J NEUROSCI, V18, P4767 | - |
dc.description.citedreference | Said SI, 1998, ANN NY ACAD SCI, V865, P226 | - |
dc.description.citedreference | Gozes I, 1997, J NEUROBIOL, V33, P329 | - |
dc.description.citedreference | Shioda S, 1997, BRAIN RES, V765, P81 | - |
dc.description.citedreference | Cha CI, 1997, BRAIN RES, V753, P235 | - |
dc.description.citedreference | ZHOU JN, 1995, NEUROBIOL AGING, V16, P571 | - |
dc.description.citedreference | HARMAR T, 1994, TRENDS PHARMACOL SCI, V15, P97 | - |
dc.description.citedreference | LUTZ EM, 1993, FEBS LETT, V334, P3 | - |
dc.description.citedreference | PISEGNA JR, 1993, P NATL ACAD SCI USA, V90, P6345 | - |
dc.description.citedreference | SREEDHARAN SP, 1993, BIOCHEM BIOPH RES CO, V193, P546 | - |
dc.description.citedreference | ISHIHARA T, 1992, NEURON, V8, P811 | - |
dc.description.citedreference | ZBUZEK V, 1988, NEUROENDOCRINOLOGY, V48, P619 | - |
dc.description.citedreference | GOZES I, 1988, NEUROENDOCRINOLOGY, V47, P27 | - |
dc.description.tc | 3 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.